SAN DIEGO, Oct. 2 /PRNewswire-FirstCall/ -- Biosite Incorporated will host its 3rd Annual Investor R&D Day Conference: Establishing Excellence in Diagnostic Innovation, on Tuesday, October 3, 2006, beginning at 9:00 AM Eastern Daylight Time.
This year's program will be moderated by Norman Paradis, M.D., Biosite's vice president of medical affairs. An updated schedule of the day, with topics and speakers, is available at http://www.biosite.com/investor/randd.aspx.
Investors and other interested parties may access this meeting by visiting the Company's Web site at www.biosite.com for a simultaneous webcast of the presentations. If you are unable to participate during the live webcast, the conference will be archived on the Biosite Web site until November 4, 2006.
For additional details, please contact: Michelle Hickman Corporate and Investor Relations Biosite Incorporated (858) 805-2419 email: mhickman@biosite.com About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of U.S. hospitals and in more than 60 international markets. Information on Biosite can be found at www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated. The Company's logo is a trademark of Biosite Incorporated.
Biosite IncorporatedCONTACT: Nadine Padilla, Vice President, Corporate and Investor Relations,+1-858-805-2820, npadilla@biosite.com, or Michelle Hickman, InvestorRelations Analyst, +1-858-805-2419, mhickman@biosite.com, both of BiositeIncorporated
